Prevalent and Rare Mutations in IL-36RN Gene in Chinese Patients with Generalized Pustular Psoriasis and Psoriasis Vulgaris  by Li, Ming et al.
CONFLICT OF INTEREST
Michael Sticherling supports Actelion, Biogen, and
Pfizer scientifically, is a member of advisory boards
of Abbott, Pfizer, MSD, and Leo, and is/was a
speaker for Abbott, Pfizer, MSD, Leo, and Janssen.
The other authors state no conflict of interest.
ACKNOWLEDGMENTS
We are grateful to all patients and their parents for
participation in this study. We thank Petra Badorf
and Daniela Hemmeter for excellent technical
assistance. We acknowledge Klaus Griewank for
critically reviewing the manuscript. The study was
partly supported by a grant from the German
Federal Ministry of Education and Research (Bun-
desministerium fu¨r Bildung und Forschung (BMBF);
project ANCYLOSS, TP5).
Andreas Ko¨rber1,9, Rotraut Mo¨ssner2,9,
Regina Renner3,9, Heinrich Sticht4,9,
Dagmar Wilsmann-Theis5,9,
Peter Schulz6, Michael Sticherling3,
Heiko Traupe7 and Ulrike Hu¨ffmeier8
1Department of Dermatology, University of
Essen, Essen, Germany; 2Department of
Dermatology, University of Go¨ttingen,
Go¨ttingen, Germany; 3Department of
Dermatology, University of Erlangen-
Nuremberg, Erlangen, Germany;
4Bioinformatics, Institute of Biochemistry,
University of Erlangen-Nuremberg, Erlangen,
Germany; 5Department of Dermatology,
University of Bonn, Bonn, Germany;
6Department of Dermatology, Fachklinik
Bad Bentheim, Bad Bentheim, Germany;
7Department of Dermatology, University of
Mu¨nster, Mu¨nster, Germany and 8Institute of
Human Genetics, University of Erlangen-
Nuremberg, Erlangen, Germany
E-mail: Ulrike.Hueffmeier@uk-erlangen.de
9These authors contributed equally to this work.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online
version of the paper at http://www.nature.com/jid
REFERENCES
Augey F, Renaudier P, Nicolas JF (2006) General-
ized pustular psoriasis (Zumbusch): a French
epidemiological survey. Eur J Dermatol
16:669–73
Blumberg H, Dinh H, Dean C Jr. et al. (2010)
IL-1RL2 and its ligands contribute to the
cytokine network in psoriasis. J Immunol
185:4354–62
Dunn EF, Gay NJ, Bristow AF et al. (2003) High-
resolution structure of murine interleukin 1
homologue IL-1F5 reveals unique loop con-
formations for receptor binding specificity.
Biochemistry 42:10938–44
Farooq M, Nakai H, Fujimoto A et al. (2013)
Mutation analysis of the IL36RN gene in 14
Japanese patients with generalized pustular
psoriasis. Human Mutation 34:176–83
Guex N, Peitsch MC, Schwede T (2009) Automated
comparative protein structure modeling
with SWISS-MODEL and Swiss-PdbViewer: a
historical perspective. Electrophoresis
30(Suppl 1):S162–73
Jordan CT, Cao L, Roberson ED et al. (2012a) Rare
and common variants in CARD14, encoding
an epidermal regulator of NF-kappaB, in
psoriasis. Am J Hum Genet 90:796–808
Jordan CT, Cao L, Roberson ED et al. (2012b)
PSORS2 is due to mutations in CARD14. Am J
Hum Genet 90:784–95
Marrakchi S, Guigue P, Renshaw BR et al. (2011)
Interleukin-36-receptor antagonist deficiency
and generalized pustular psoriasis. New Engl J
Med 365:620–8
Onoufriadis A, Simpson MA, Pink AE et al. (2011)
Mutations in IL36RN/IL1F5 are associated
with the severe episodic inflammatory
skin disease known as generalized pustular
psoriasis. Am J Hum Genet 89:432–7
Sayle RA, Milner-White EJ (1995) RASMOL: bio-
molecular graphics for all. Trends Biochem
Sci 20:374
Schouten JP, McElgunn CJ, Waaijer R et al. (2002)
Relative quantification of 40 nucleic acid
sequences by multiplex ligation-dependent
probe amplification. Nucleic Acids Res
30:e57
Sugiura K, Takeichi T, Kono M et al. (2012) A
novel IL36RN/IL1F5 homozygous nonsense
mutation, p.Arg10X, in a Japanese
patient with adult-onset generalized pustular
psoriasis. Br J Dermatol 167:699–701
Vigers GP, Anderson LJ, Caffes P et al. (1997)
Crystal structure of the type-I interleukin-1
receptor complexed with interleukin-1beta.
Nature 386:190–4
Viguier M, Guigue P, Pages C et al. (2010)
Successful treatment of generalized pustular
psoriasis with the interleukin-1-receptor
antagonist Anakinra: lack of correlation with
IL1RN mutations. Ann Intern Med 153:66–7
Prevalent and Rare Mutations in IL-36RN Gene in Chinese
Patients with Generalized Pustular Psoriasis and Psoriasis
Vulgaris
Journal of Investigative Dermatology (2013) 133, 2637–2639; doi:10.1038/jid.2013.267; published online 18 July 2013
TO THE EDITOR
Generalized pustular psoriasis (GPP;
OMIM 614204) is a severe type of
psoriasis characterized by widespread
erythematous skin and sterile pustules.
The acute onset is typically associated
with high-grade fever, rigor, and toxi-
city. Psoriasis vulgaris (PV; OMIM
177900) is the most common form of
psoriasis, which is an immune-mediated
inflammatory skin disease with scaly
and well-demarcated red plaques.
Although GPP is traditionally classified
as a variant of PV, the common mech-
anisms of pathogenesis remain unclear
(Setta-Kaffetzi et al., 2013).
Recently, a homozygous loss-of-
function mutation in IL-36RN, L27P,
was first identified in GPP patients
(Marrakchi et al., 2011). On the other
hand, different mutations were found
by exome sequencing on unrelated
individuals with GPP in Caucasians
(Onoufriadis et al., 2011). Of note,
our previous study in 10 Chinese
GPP patients showed that only one
known polymorphism, c.227C4T, was
identified in one patient (Li et al.,
2012). We also found the c.115þ
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6T4C variant in three GPP patients as
well as in healthy controls. As the case
number was so limited at that time, it
was premature to identify the asso-
ciation between GPP and the mutation
c.115þ6T4C, while the following
study conducted by Farooq et al.
(2012) found the same mutation. Their
study prompted us to further investigate
IL-36RN mutations in Chinese patients
with GPP and PV. In addition, we
compared the association between
IL-36RN mutations with paediatric-
onset GPP (PGPP) and adult-onset GPP
(AGPP). For detailed information of
Materials and Methods see Supplemen-
tary Information online.
Four mutations, namely, c.115þ
6T4C, p.Asn47Ser, p.Pro76Leu, and
p.Arg102Gln, were identified in GPP
patients (Supplementary Figure S2
online). Three mutations (c.115þ
6T4C, p.Asn47Ser, and p.Pro76Leu)
were identified in PV patients and in
healthy controls. Mutation c.115þ
6T4C was the most common mutation
in GPP. The percentage of c.115þ
6T4C was 3.6% in the normal controls.
Interestingly, the c.115þ6T4C variant
was also identified in two normal con-
trols in a homozygous state, and they are
both at an age over 40.
The percentage of IL-36RN mutations
was 48.5% in GPP patients. These
variants were also carried by 10.7% of
the control individuals. The associations
between the most common mutation
c.115þ6T4C and GPP of either group
was statistically significant comparing
with controls (PGPP: P¼ 3.98 10 22,
AGPP: P¼ 1.15 108) (Table 1).
Mutation Pro76Leu was also signifi-
cantly associated with GPP of either
group statistically comparing with controls
(PGPP: P¼ 1.4910 3; AGPP: P¼
0.024) (Table 1). The other two rarer IL-
36RN variants (Asn47Ser and Arg102Gln)
were not associated with GPP when ana-
lyzed individually. However, the combi-
ned genotype showed a highly significant
association (P¼6.261022) (Table 1).
The frequency of IL-36RN mutations was
34.2 vs. 66.7% in PGPP and AGPP
patients, respectively (P¼ 0.008). Twenty
cases (66.7%) with PGPP and 11 cases
(28.9%) with AGPP were identified
to be carriers of common mutation
c.115þ6T4C (P¼ 0.0035) (Table 1).
The allele of c.115þ 6T4C also demon-
strated significant difference in the AGPP
and PGPP groups (P¼1.46105,
odds ratio (OR)¼4.83, 95% confidence
interval (CI): 2.32–10.06) (Table 2).
About 9% PV patients were found to
be heterozygote for mutation Asn47Ser,
which was higher than that for mutation
c.115þ6T4C or Pro76Leu. However,
no significant relationship was found
between mutation Asn47Ser and PV
(P¼ 0.53) (Table 1). Mutation c.115þ
6T4C was merely found in 1.8% of PV
patients, the allele of which showed no
association with PV (P¼0.387, OR¼
0.42, 95% CI: 0.09–1.87) (Table 2). A
total of 12 (11.9%) patients with PV
were heterozygote carriers for IL-36RN
mutations. The association between PV
and combined genotype was not signifi-
cant (P¼0.74) (Table 1).
To date, 11 IL-36RN mutations
(p.Arg10X, p.Leu27Pro, p.Lys35Arg,
c.115þ 6T4C, p.Asn47Ser, p.Arg48Trp,
p.Pro76Leu, p.Arg102Gln, p.Arg
102Trp, p.Ser113Leu, and p.Thr123Arg)
have been identified in African, Eur-
opean, and Asian populations. In the
current study, four IL-36RN mutations
were identified in the GPP cohort.
Mutation c.115þ 6T4C was the most
common mutation in the GPP and
normal controls. This mutation has been
reported in Japanese and Malay popula-
tions, but it was not found in European
and African populations (Sugiura et al.,
Table 1. The four IL-36RN mutations in GPP and PV patients
c.115þ 6 T4C p.Asn47Ser p.Pro76Leu p.Arg102Gln Combined
Genotype Con PGPP AGPP PV Con PGPP AGPP PV Con PGPP AGPP PV Con PGPP AGPP PV Con PGPP AGPP
All
GPP PV
AA 352 10 27 111 348 28 35 101 366 27 36 111 372 30 37 108 328 10 25 35 89
Aa 11 2 2 2 24 2 2 10 1 3 2 1 0 0 1 0 37 2 4 6 12
aa 2 18 9 0 1 0 1 0 0 0 0 0 0 0 0 0 2 18 9 27 0
Total 365 30 38 113 373 30 38 111 367 30 38 112 372 30 38 108 365 30 38 68 101
P – 3.98E–22 1.15E–08 0.85 – 1 0.24 0.53 – 0.001 0.02 0.41 – – 0.09 – – 3.64E–
21
1.20E–
08
6.26E–
22
0.74
P (PGPP
versus AGPP)
– – 0.004 – – – 1 – – – 0.64 – – – 1 – – – 0.008 – –
Abbreviations: AGPP, adult-onset generalized pustular psoriasis; Con, control; GPP, generalized pustular psoriasis; PGPP, pediatric-onset generalized pustular
psoriasis; PV, psoriasis vulgaris.
Table 2. Comparison of the allele of the variant (115þ 6T4C) in GPP and
PV patients
Allele
a A
P (compared
with control) OR (95% CI)
P (PGPP
versus AGPP) OR (95% CI)
Con 15 715 – 1.00
PGPP 38 22 2.56E74 82.33 (39.56–171.34) 1.46E 05 4.83 (2.32–10.06)
AGPP 20 56 5.29E23 17.02 (8.26–35.06)
PV 2 224 0.387 0.42 (0.09–1.87)
Abbreviations: AGPP, adult-onset generalized pustular psoriasis; CI, confidence interval; Con, control;
GPP, generalized pustular psoriasis; OR, odds ratio; PGPP, pediatric-onset generalized pustular
psoriasis; PV, psoriasis vulgaris.
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2012; Setta-Kaffetzi et al., 2013). The
most common mutations p.Ser113Leu in
European population and p.Leu27Pro in
African population were not found
in the cohorts of the current study
(Setta-Kaffetzi et al., 2013). These
results indicate that IL-36RN muta-
tions in the Chinese population
dramatically differed from that in the
European and African population. In
this study, the mutation c.227C4T
was found on the same chromosome
as the c.115þ 6T4C allele in GPP
patients as Setta-Kaffetzi et al.
reported previously in Malay and
Chinese population. These results
indicated that c.227C4T-c.115þ
6T4C allele may be the founder
allele in Asian populations.
Interestingly, the c.115þ6T4C var-
iant was identified in two normal con-
trols in homozygous state in this study,
implying that multiple factors should
contribute to the pathogenesis of GPP.
Setta-Kaffetzi et al. found that six GPP
cases carried heterozygous mutations in
IL-36RN. They speculated that the GPP
patients with a single IL-36RN variant
may represent cases of tri-allelic disease
inheritance. IL-38, another member
of IL-1 family, specifically bound to
IL-36R, had a similar biological
role in the immune responses (Van
de Veerdonk et al., 2012). Of note,
evidence showed that IL-38 could
bind to IL-36R, which might be a
compensative mechanism in healthy
individuals with the mutant IL-36RN.
In addition, GPP patients with no
mutations in IL-36RN gene also had
overexpressing inflammatory cytokines,
which was similar to the GPP patients
with specific mutation in other genes
(Towne et al., 2011).
Although the mutations of IL-36RN
are strongly associated with GPP, there
existed no significant association
between IL-36RN mutations and PV in
this study (P¼ 0.746). The impaired
function of mutant IL-36RN in GPP
patients might attenuate the specific
inhibitory effect on the proinflammatory
activation of IL-36, while keratinocytes
in PV patients could overexpress
IL-36 lastingly through the circular
induction of IL-36 and TNF, IL-17,
and IL-22 (Carrier et al., 2011;
Johnston et al., 2011) The existing data
indicated that the mechanism of
overexpression of IL-36 in PV differed
from that of GPP.
In this study, it was remarkable that
the percentage of IL-36RN mutations
of PGPP patients was much higher than
that of AGPP patients. We speculated
that heritable factors might have a
more important role in PGPP compared
with AGPP patients. On the other hand,
the age of GPP onset differed in
the c.115þ 6T4C mutant individuals,
which also suggested that the specific
immunological or biological environ-
ment might lead to various pathogenical
results. For example, the avoidance of
the several triggering factors, such as
bacterial infection, mediation, stress,
and hypocalcemia, might delay the onset
of GPP (Zelickson and Muller, 1991).
Taken together, the data above
strongly indicated the existence of envir-
onmental factors or other regulatory
genes may also have a role in the
pathogenic process of GPP.
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